Financials
- Market Capitalization 1.19 B
- Employee 37
- Founded 2014
- CEO N/A
- Website www.corvuspharma.com
- Headquarter Delaware, United States
- FIGI BBG009F0TGH8
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-14.53
売上高対価格比率
—
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2311 | MNKD MannKind Corporation - Common Stock | 3.95 USD | -2.71% | -4.59% | +1.28% | -25.47% | 1.27 B USD | ||
| 2313 | IMTX Immatics N.V. - Ordinary Shares | 9.45 USD | +0.96% | +6.66% | +4.42% | -8.70% | 1.27 B USD | ||
| 2356 | SANA Sana Biotechnology, Inc. - Common Stock | 3.93 USD | -3.91% | +1.29% | +23.97% | +30.56% | 1.18 B USD | ||
| 2371 | GLUE Monte Rosa Therapeutics, Inc. - Common Stock | 13.38 USD | -6.56% | -4.56% | -39.43% | +18.41% | 1.14 B USD |